FDA plant warnings have increased of late; Trans-Pacific Partnership has reduced pharma companies' access to some pacific countries, says Shenoy. | Subscribe To Our Free Newsletter |
Pharma looks best export theme, valuations attractive: Deepak Shenoy
FDA plant warnings have increased of late; Trans-Pacific Partnership has reduced pharma companies' access to some pacific countries, says Shenoy. 